Showing results (1-10 of 5,377) with videos related to
Sort By:
Pageof 538
Trends in Immunology|June 1, 2005
PTX cruiser: driving autoimmunity via TLR4Michael K Racke, Wei Hu, Amy E Lovett-RackeCellular Immunology|July 27, 2002
Retinoic acid promotes the development of Th2-like human myelin basic protein-reactive T cellsAmy E Lovett-Racke, Michael K RackeJournal of Immunology (Baltimore, Md. : 1950)|February 4, 2011
Glatiramer acetate treatment of multiple sclerosis: an immunological perspectiveMichael K Racke, Amy E Lovett-RackePPAR Research|January 15, 2011
Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARsYuhong Yang, Amy E Lovett-Racke, Michael K RackeBiochimica Et Biophysica Acta|July 6, 2010
Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis?Amy E Lovett-Racke, Yuhong Yang, Michael K RackeJournal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 2, 2014
Is T-bet a potential therapeutic target in multiple sclerosis?Michael K Racke, Yuhong Yang, Amy E Lovett-RackeNeurology|December 30, 2009
The mechanism of action of glatiramer acetate treatment in multiple sclerosisMichael K Racke, Amy E Lovett-Racke, Nitin J KarandikarArchives of Neurology|September 10, 2008
Monoclonal antibody therapies and neurologic disordersJohn C Novak, Amy E Lovett-Racke, Michael K RackeExpert Review of Clinical Immunology|May 19, 2010
Novel therapeutic strategies targeting the pathogenic T-cells in multiple sclerosisMark T Muir, Amy E Lovett-Racke, Michael K RackeBrain, Behavior, and Immunity|December 16, 2014
Analysis of TGF-β1 and TGF-β3 as regulators of encephalitogenic Th17 cells: Implications for multiple sclerosisPriscilla W Lee, Yuhong Yang, Michael K Racke, et al.Pageof 538